Home Stock

Stock Research: Fresenius

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Fresenius

GER:FRE DE0005785604
79
  • Value
    34
  • Growth
    76
  • Safety
    Safety
    75
  • Combined
    77
  • Sentiment
    65
  • 360° View
    360° View
    79
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Fresenius SE & Co KGaA is a Germany-based healthcare company. It operates in healthcare products for critically and chronically ill patients (Fresenius Kabi), private hospital operations (Fresenius Helios), services for hospitals and healthcare facilities (Fresenius Vamed), and dialysis products and services (Fresenius Medical Care). In the last fiscal year, the company had 176486 employees, a market capitalization of $26975 million, profits of $5568 million, and revenue of $22604 million.

more

ANALYSIS: With an Obermatt 360° View of 79 (better than 79% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Fresenius are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Fresenius. The consolidated Growth Rank has a good rank of 76, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 76% of competitors in the same industry. The consolidated Safety Rank at 75 means that the company has a financing structure that is safer than 75% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 65, which means that professional investors are more optimistic about the stock than for 65% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 34, meaning that the share price of Fresenius is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 66% of alternative stocks in the same industry. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Profit Growth
Country Germany
Industry Health Care Services
Size X-Large
Website fresenius.com
Index
CDAX
DAX 40
Fresenius stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 7-May-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
34 94 92 97
Growth
76 94 37 43
Safety
Safety
75 53 75 54
Sentiment
65 46 76 13
360° View
360° View
79 93 96 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
70 81 55 57
Opinions Change
56 53 64 37
Pro Holdings
n/a 16 84 26
Market Pulse
28 33 39 14
Sentiment
65 46 76 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
34 94 92 97
Growth
76 94 37 43
Safety Safety
75 53 75 54
Combined
77 98 90 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
57 71 77 91
Price vs. Earnings (P/E)
72 90 90 97
Price vs. Book (P/B)
77 84 88 93
Dividend Yield
1 78 82 78
Value
34 94 92 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
43 34 1 27
Profit Growth
89 94 56 15
Capital Growth
82 82 68 81
Stock Returns
36 88 61 57
Growth
76 94 37 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
60 31 36 28
Refinancing
73 67 95 65
Liquidity
57 42 37 44
Safety Safety
75 53 75 54

Similar Stocks

Discover high‑ranked alternatives to Fresenius and broaden your portfolio horizons.

Volkswagen VW

GER:VOW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Philips

AEX:PHIA
Country: Netherlands
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Hornbach Holding

GER:HBH
Country: Germany
Industry: Home Improvement Retail
Size: Large
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews